Latest news and research on all cancers and treatments, updated several times a week
“Treatment with the checkpoint inhibitor nivolumab led to impressively "frequent and long-lasting" response rates in Hodgkin's lymphoma, even in heavily pre-treated patients
“the implication of a clinical trial that showed people with HIV who undergo transplant for lymphoma have outcomes similar to people without the virus
Dunedin-based Pacific Edge has released today the second product in its suite of diagnostic tests for the detection and management of bladder ...
Pacific Edge launches second bladder test in NZ, flags US launch next year - The National Business Review (subscription)
The drug has already demonstrated benefit in the treatment of other cancers, particularly melanoma, renal cell cancer, lung cancer and bladder cancer ...
The Dunedin-based non-invasive bladder cancer test developer launched its second cancer test in New Zealand and flags a US launch early next ...
We are seeing durable responses in lung cancer, bladder cancer, gastric cancer, head and neck cancer, Hodgkin's disease, breast cancer. The list ...
Patients with classical Hodgkin lymphoma whose cancer had failed to respond to ... The immunotherapy drugs tested in the trials helped the Hodgkin ...
Bristol-Myers Squibb, Merck & Co Drugs Show Promise In Early Trials For Hodgkin's Lymphoma - Bidness ETC
[Dr. Patrick Soon-Shiong: We now have patients with pancreatic cancer that are free of metatheses for five years. ... He's involved in immunotherapy.
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT: CVM) today announced that during November it has added seven new clinical ...
But it hasn't always been so, said Agenus CEO Garo Armen, whose immunotherapy approach in bothcancer and in infectious disease like herpes had ...
The clinical trial, which will be the first-in-human study of Advaxis's lead Lm-LLO immunotherapy product candidate in prostate cancer, is expected to ...
Advaxis Announces FDA Acceptance of Its Investigational New Drug Application to Commence ... -MarketWatch
A therapy that liberates the immune system to attack cancer cells drove ... While clinical trials of such immunotherapies in other cancers have shown ...
This microscope image shows many of the immune system's dendritic cells that were collected from a 3D scaffold three days after in vivo injection.
... laboratory experiments conducted to date, some credit mistletoe extract with killing cancer cells in animals and boosting the body's immune system, ...
... come back, and they revealed what the team originally feared two weeks ago: The 25-year old has lymphoma, a cancer of the immune system.
A new cancer treatment from Novartis ($NVS) and its partners at the ... promise of therapies that train the immune system to bear down on tumor cells.
Harnessing the power of the immune system to target and destroy cancer cells has long been a goal of scientists and physicians alike, but creating ...
It is said to alert the body's immune system to cancer cells, allowing immune cells to attack and destroy them more effectively than some other ...
Buckle Your Seatbelts: Cancer Centers Fly 'Very' Friendly Skies
You have just buckled in for your flight and you begin thumbing through the airline's magazine, when a series of articles on cancer treatment catches your eye. You settle back to read what appears to be a series devoted to cutting edge treatments being done at leading institutions around the country. FULL STORY»
You have just buckled in for your flight and you begin thumbing through the airline's magazine, when a series of articles on cancer treatment catches your eye. You settle back to read what appears to be a series devoted to cutting edge treatments being done at leading institutions around the country. FULL STORY»
Cancer News in Science Daily
“Researchers have shown how a topical steroid cream frequently used to treat common skin conditions, can be used to improve dermatitis in cancer patients. Radiotherapy uses X-rays to destroy cancer cells but this can often lead to a severe skin reaction involving redness, pain and blistering similar to sunburn. The trial of this cream -- mometasone furoate--was so successful that the patients in the research will now be offered this instead of the existing treatment.
“Cancer therapy can be much more effective using a new way to customize nuclear medicine treatment, researchers say. The process could also be useful for other diseases that could benefit from targeted radiation.
“It may be possible to develop a simple blood test that, by detecting changes in the zinc in our bodies, could help to diagnose breast cancer early, scientists say. In a world-first, the researchers were able to show that changes in the isotopic composition of zinc, which can be detected in a person's breast tissue, could make it possible to identify a 'biomarker' (a measurable indicator) of early breast cancer.
“Common variations in four genes related to brain inflammation or cells' response to damage from oxidation may contribute to the problems with memory, learning and other cognitive functions seen in children treated for acute lymphoblastic leukemia, according to a research. The findings suggest the possibility of screening ALL patients for their risk of long-term treatment-related effects on memory, attention and learning and studying potential interventions.
“A key factor that can suppress medulloblastoma, the most frequent child brain tumor, has been identified by researchers. Medulloblastoma is the most common brain tumor in children, and its treatment remains inefficient. The work opens new perspectives on the diagnosis and treatment of these brain tumors with the discovery of a key factor called BCL6, able to suppress the growth of medulloblastomas in mice and in human tumor cells in culture.
Increased use of hypofractionated whole-breast irradiation for patients with early-stage breast cancer
“The use of hypofractionated whole-breast irradiation (HF-WBI) for patients with early-stage breast cancer increased 17.4 percent from 2004 to 2011, and patients are more likely to receive HF-WBI compared to conventionally fractionated whole-breast irradiation (CF-WBI) when they are treated at an academic center or live ≥50 miles away from a cancer center, according to a study.
“Despite significant drops in smoking rates, cigarettes continue to cause about three in ten cancer deaths in the United States, a study has found. "Reducing smoking prevalence as rapidly as possible should be a top priority for US public health efforts to prevent future cancer deaths," the authors say.
“Near-perfect replications of human and animal cells enables improved study of certain cancers and stem cells, as well as the creation of complex durable objects without machinery, scientists report. A new technique to transmute living cells into more permanent materials that defy decay and can endure high-powered probes is widening research opportunities for biologists who are developing cancer treatments, tracking stem cell evolution or even trying to understand how spiders vary the quality of the silk they spin.
Platinum agent combination treatment for triple-negative breast cancer well tolerated in phase II clinical trial
“New research shows that a combination of doxil, carboplatin and bevacizumab is a well-tolerated treatment regimen in patients with metastatic triple-negative breast cancer who received no prior treatment for their metastatic disease. The work also included genomic profiling to measure molecular correlates of response.
“Radiation therapy for head and neck cancer is highly complex, and a new study suggests that medical centers with more experience centers have better patient outcomes. The study compared survival and other outcomes in 470 patients treated with radiation therapy at 101 treatment centers through a clinical trial held from 2002 to 2005.
“A multicenter phase 1 trial of the immune checkpoint blocker ipilimumab found clinical benefit in nearly half of blood cancer patients who had relapsed following allogeneic stem cell transplantation, according to investigators.
Tambahkan Komentar